Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Glutathione S-transferase (GSTM1, GSTT1 and GSTA1) polymorphisms and outcomes after treatment for acute myeloid leukemia: pharmacogenetics in Southwest Oncology Group (SWOG) clinical trials

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Joel SP, Rohatiner A . Pharmacology of antileukemic drugs. In: Henderson ES, Lister TA, Greaves MF (eds). Leukemia, Saunders: Philadelphia, PA, 2002, pp 394–440.

    Google Scholar 

  2. Hayes JD, McLellan LI . Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Radic Res 1999; 31: 273–300.

    Article  CAS  PubMed  Google Scholar 

  3. Ambrosone CB, Tian C, Ahn J, Kropp S, Helmbold I, von Fournier D et al. Genetic predictors of acute toxicities related to radiation therapy following lumpectomy for breast cancer: a case-series study. Breast Cancer Res 2006; 8: R40.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Leith CP, Kopecky KJ, Godwin J, McConnell T, Slovak ML, Chen IM et al. Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study. Blood 1997; 89: 3323–3329.

    CAS  PubMed  Google Scholar 

  5. Autrup JL, Hokland P, Pedersen L, Autrup H . Effect of glutathione S-transferases on the survival of patients with acute myeloid leukaemia. Eur J Pharmacol 2002; 438: 15–18.

    Article  CAS  PubMed  Google Scholar 

  6. Voso MT, D'Alo F, Putzulu R, Mele L, Scardocci A, Chiusolo P et al. Negative prognostic value of glutathione S-transferase (GSTM1 and GSTT1) deletions in adult acute myeloid leukemia. Blood 2002; 100: 2703–2707.

    Article  CAS  PubMed  Google Scholar 

  7. Naoe T, Tagawa Y, Kiyoi H, Kodera Y, Miyawaki S, Asou N et al. Prognostic significance of the null genotype of glutathione S-transferase-T1 in patients with acute myeloid leukemia: increased early death after chemotherapy. Leukemia 2002; 16: 203–208.

    Article  CAS  PubMed  Google Scholar 

  8. Davies SM, Robison LL, Buckley JD, Tjoa T, Woods WG, Radloff GA et al. Glutathione S-transferase polymorphisms and outcome of chemotherapy in childhood acute myeloid leukemia. J Clin Oncol 2001; 19: 1279–1287.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This investigation was supported in part by the following PHS Cooperative Agreement Grant numbers awarded by the National Cancer Institute, DHHS: CA38926, CA32102, and from a grant from the Southwest Oncology Group Hope Foundation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C B Ambrosone.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Weiss, J., Kopecky, K., Godwin, J. et al. Glutathione S-transferase (GSTM1, GSTT1 and GSTA1) polymorphisms and outcomes after treatment for acute myeloid leukemia: pharmacogenetics in Southwest Oncology Group (SWOG) clinical trials. Leukemia 20, 2169–2171 (2006). https://doi.org/10.1038/sj.leu.2404421

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2404421

This article is cited by

Search

Quick links